SIME Diagnostics, a UK-based medical technology company today announced the completion of a clinical study [...]
LONDON, May 13, 2020 – SIME Clinical AI, a pioneer in applying AI and data [...]
A recent peer reviewed letter to editor by SIME has been published in Critical Care [...]
Partnership will accelerate path to commercialisation of novel respiratory diagnostics LONDON, May 7, 2020 /PRNewswire/ — Today, [...]
Data demonstrating that AI accurately predicts Respiratory Distress Syndrome (RDS) in premature babies, enables company [...]
SIME Dx today announced that the European Patent Office intends to grant patent number 14727196.9 [...]
At SIME Diagnostics we are developing a digital platform that can measure multiple biomarkers, from [...]
LONDON, August 15, 2018 /PRNewswire/ — Device fully automates neonatal Lung Maturity Test (LMT),representing a major milestone achievement andputtingLMT on track for final clinical validation and [...]
Project Delivers Strong Clinical Data, IP and Prototype of Rapid Neonatal Lung Maturity Test LONDON, Jan. [...]
In December of 2016, Microsoft UK published a feature article about SIME Dx’s bedside test, [...]
